You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Cancer start-up will get $47m

Jounce to focus on immunotherapy; Third Rock has started 21 companies

Boston venture capital firm Third Rock Ventures is set to disclose Thursday that it is putting up $47 million to launch a cancer immunotherapy start-up in Cambridge.

The company will be called Jounce Therapeutics Inc., a name derived partly from a well-known physics term and partly from a synonym for jolt. It is meant to signal the dramatic change the company and its financial backers expect from their cancer-fighting approach.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week